Home › Plasmablastic Lymphoma › Maryland
Plasmablastic Lymphoma clinical trials in Maryland
4 studies for Plasmablastic Lymphoma are looking for participants at sites in Maryland.
AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study")
- AIDS Malignancy Consortium, Rockville
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07649304A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
RecruitingEarly phase 1
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT04139304Pomalidomide and Dose-Adjusted EPOCH +/- Rituximab for HIV-Associated Lymphomas
- National Institutes of Health Clinical Center, Bethesda
RecruitingPhase 1
Ages 18 to 120 · All sexes · Updated Aug 25, 2026 · NCT05389423Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT05663502From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.